Programme Day 1 - June 3rd 2008

Welcome, David Badcock, Mainliners

Session 1

Migrating and Mitigating HCV Politics
Chair: David Badcock, Mainliners

Progressing Hepatitis C in public health environments
Dr Jeffrey Lazarus, WHO (Europe), Copenhagen

Hepatitis C in European nations - An overview of HCV activity in Germany
Achim Kautz, Deutsche Leberhilfe e.V., Germany

Hepatitis C in European nations - An overview of HCV activity in  Belgium
Muriel Colinet, Presidente du CHAC, Belgium

World Hepatitis Alliance
Charles Gore, Hepatitis C Trust

Q and A

Tea and Coffee

Session 2

Scratching the Surface of HCV Case Finding
Chair: Dr Sheila Bird, University of Cambridge

Translating national awareness campaigns
Ben Caspersz, Munro and Forster, London, UK

Effective case finding and lessons learned in Canada
Jeff R. Potts, Public Health Agency of Canada

Q and A

Lunch

Session 3

Parallel Abstract Presentation Session

Abstract presentations    Poster Presentations Day 1

Session 4

Engaging with at Risk Groups for HCV
Chair: Levinia Crooks, Chief Executive Officer, Australasian Society for HIV Medicine, Australia

Cultural awareness and reaching out effectively to ethnic groups,
Prof Graham Foster, Barts and The London School of Medicine

HCV Harm Reduction Literature: Are we reaching out effectively to
Injecting Drug Users?
Prof Avril Taylor, University of the West of Scotland, Scotland

Q and A

Tea and Coffee

Session 5

Managing Mental Health and Social Care for Successful Testing and Treatment
Chair: Dr Stephan Janikiewicz, Cheshire & Wirral partnership NHS

Progression towards and through HCV treatment,
Dr Vanessa Crawford, East London and the City Addiction Services, UK

Care beyond the HCV infection,
Ian Robertson, Fife Positive Support, Scotland

Q and A

Social Session

Debate: Is Drug Use a Medical or Legal Problem
Chair: Prof Graham Foster, Barts and The London School of Medicine

Leon Wylie, Scottish Association of Alcohol and Drug Action Teams (SAADAT)
Dr Stephan Janikiewicz, Cheshire & Wirral partnership NHS Trust
Social session debate - cheese & wine will be available in the sunken lounge for the debate session.

Programme Day 2 - June 4th 2008

Welcome
Dr Nicola Rowan, UK Hepatitis C Resource Centre, Mainliners, UK

Session 1

Can National Action Plans Marry Best Practice and Cost Effectiveness for Hepatitis C
Chair: Dr Jeffrey Lazarus, WHO (Europe), Copenhagen

Evidenced based action plans – a costed model to tackle hepatitis C,
Prof David Goldberg, Health Protection Scotland

Can we assess the impact of injecting equipment distribution for HCV prevention
Dr Matthew Hickman, University of Bristol, UK

Hepatitis C Prevention, Support and Research Program for Canada
Jeff R. Potts, Public Health Agency of Canada

Q and A

Tea and Coffee

Session 2

Harm Reduction Interventions and Lessons Learned
Chair: Harry Shapiro, Drugscope

Novel HCV harm reductions approaches in Australia
Levinia Crooks, Australasian Society for HIV Medicine, Australia

Does introducing needle exchange in prison pose more or less harm?
Prof Heino Stoever, University of Bremen, Germany

Q and A

Lunch

Session 3

Parallel Abstract Presentation Session

Abstract presentations  Poster presentations day 2

Session 4

Is Anti-Viral Treatment in the Community the Future Model for Effective HCV Treatment
Chair: Achim Kautz, Deutsche Leberhilfe e.V., Germany

UK lessons learned so far in treating HCV in the community
Dr Steve Ryder, Nottingham University Hospitals NHS Trust, UK

Progressing to treat hepatitis C in large numbers across Egypt
Prof Gamal El-Sayed Shiha, Mansoura University, Egypt

Expanding access to hepatitis C treatment in the Australian community
Levinia Crooks, Australasian Society for HIV Medicine, Australia

Q and A

Close of Conference